ArticleBMC cancer2021

CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.

Elodie Coquan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.